Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets EXMKT - Delayed Quote USD

THC Biomed Intl Ltd. (THCBF)

Compare
0.0010
0.0000
(0.00%)
At close: April 2 at 4:00:00 PM EDT
Loading Chart for THCBF
  • Previous Close 0.0245
  • Open 0.0245
  • Bid 0.0098 x --
  • Ask 0.0245 x --
  • Day's Range 0.0245 - 0.0245
  • 52 Week Range 0.0010 - 0.0337
  • Volume 394
  • Avg. Volume 261
  • Market Cap (intraday) 2.401M
  • Beta (5Y Monthly) 0.09
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. It offers cannabis beverage shots, gummies, and biscuits under the THC KISS brand names, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.

thcbiomed.com

35

Full Time Employees

July 31

Fiscal Year Ends

Recent News: THCBF

View More

Performance Overview: THCBF

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

THCBF
0.00%
S&P/TSX Composite index (^GSPTSE)
1.16%

1-Year Return

THCBF
93.67%
S&P/TSX Composite index (^GSPTSE)
10.05%

3-Year Return

THCBF
98.24%
S&P/TSX Composite index (^GSPTSE)
10.85%

5-Year Return

THCBF
98.58%
S&P/TSX Composite index (^GSPTSE)
88.09%

Compare To: THCBF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: THCBF

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    163.94k

  • Enterprise Value

    3.38M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.08

  • Price/Book (mrq)

    0.05

  • Enterprise Value/Revenue

    1.69

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -164.79%

  • Return on Assets (ttm)

    -15.27%

  • Return on Equity (ttm)

    -56.47%

  • Revenue (ttm)

    2.23M

  • Net Income Avi to Common (ttm)

    -3.67M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    205.01k

  • Total Debt/Equity (mrq)

    102.25%

  • Levered Free Cash Flow (ttm)

    1.07M

Research Analysis: THCBF

View More

Company Insights: THCBF

Research Reports: THCBF

View More

People Also Watch